Accuray Incorporated to Report Financial Results for Second Quarter Fiscal 2013

Thu Jan 17, 2013 8:30am EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130117:nPnSF44109


SUNNYVALE, Calif.,  Jan. 17, 2013  /PRNewswire/ -- Accuray Incorporated (Nasdaq:
ARAY), the premier radiation oncology company, today announced that it will
report results for its second quarter of fiscal 2013, ended  December 31, 2012 
on  Wednesday, February 6, 2013  after the market closes.  

A conference call to review the results will begin at  2:00 p.m. PST/5:00 p.m.
EST  and will be hosted by  Joshua H. Levine, president and chief executive
officer and  Derek Bertocci, senior vice president and chief financial officer.

The conference call dial-in numbers are 1-866-761-0749 (USA) or 1-617-614-2707
(International), Conference ID: 63591669. In addition, a dial-up replay of the
conference call will be available beginning  February 6, 2013  at  5:00 p.m.
PST/8:00 p.m. EST  and ending on  February 13, 2013. The replay telephone number
is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 
63531003.

A live webcast of the call will also be available from the Investor Relations
section of the corporate website at  http://www.accuray.com/investors.  A
webcast replay can be accessed on the corporate website beginning  Wednesday,
February 6, 2013  at approximately  5:00 p.m. PST/8:00 p.m. EST.  The replay
will remain available until Accuray announces its results for the third quarter
of fiscal 2013, ending  March 31, 2013.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that
develops, manufactures and sells personalized, innovative treatment solutions
that set the standard of care with the aim of helping patients live longer,
better lives. The Company's leading-edge technologies deliver the full range of
radiation therapy and radiosurgery treatments. For more information, please
visit  www.accuray.com.

 Contacts:  Investor Contact:                    Media Contact:                       
            
Tom Rathjen                         
Stephanie Tomei                     
            
Vice President, Investor Relations  
Director, Corporate Communications  
            
+1 (408) 789-4458                   
+1 (408) 789-4234                   
            
trathjen@accuray.com                
stomei@accuray.com                  


SOURCE  Accuray Incorporated

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.